PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
US11608342B2 · kind B2 · utility
0Cited by
56References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2020 |
| Grant date | Mar 21, 2023 |
| Priority date | — |
| Expiry date | Dec 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to PDE9 inhibitors and their use for treatment of benign prostate hyperplasia and sickle cell disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.